20-23364430-AC-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_022482.5(GZF1):c.49delC(p.Leu17fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Consequence
GZF1
NM_022482.5 frameshift
NM_022482.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.02
Genes affected
GZF1 (HGNC:15808): (GDNF inducible zinc finger protein 1) Enables DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.977 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-23364430-AC-A is Pathogenic according to our data. Variant chr20-23364430-AC-A is described in ClinVar as [Pathogenic]. Clinvar id is 2841879.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GZF1 | NM_022482.5 | c.49delC | p.Leu17fs | frameshift_variant | 2/6 | ENST00000338121.10 | NP_071927.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GZF1 | ENST00000338121.10 | c.49delC | p.Leu17fs | frameshift_variant | 2/6 | 1 | NM_022482.5 | ENSP00000338290.5 | ||
GZF1 | ENST00000377051.2 | c.49delC | p.Leu17fs | frameshift_variant | 1/5 | 1 | ENSP00000366250.2 | |||
GZF1 | ENST00000424216.1 | c.49delC | p.Leu17fs | frameshift_variant | 3/3 | 5 | ENSP00000410009.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 01, 2023 | This sequence change creates a premature translational stop signal (p.Leu17Tyrfs*17) in the GZF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GZF1 are known to be pathogenic (PMID: 28475863). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with GZF1-related conditions. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.